However, Meex et al. found that Fetuin-B upregulation in mice was due to an inflammatory status and not related to some biomarkers of obesity, IR, inflammation, and dyslipidemia in their study populations [10]. The gene discussed is FETUB; the disease is metabolic syndrome.